2022 Annual Meeting | C149 - Mild Cognitive Impairment/Subjective Cognitive Impairment

Date Thursday 04/07/22

Time 07:00 AM - 09:00 AM PDT Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program will be available in the meeting's On Demand product.

Event Type Seminar

Director(s) Ronald C. Petersen, MD, PhD, FAAN

Topic(s) Aging, Dementia, and Behavioral Neurology

Learning Objectives Participants should understand current practice of diagnosing mild cognitive impairment; apply the diagnosis of mild cognitive impairment to clinical practice; employ reasonable evaluation strategy for persons with MCI; analyze data regarding the typical and atypical etiologies of the syndrome of MCI; and evaluate potential treatments for MCI in the setting of disease modifying therapies for Alzheimer's disease.

CME Available 2.00 CME credits

Core Competencies Patient Care & Procedural Skills, Interpersonal and Communication Skills, Medical Knowledge, Practice-based Learning and Improvement

Program Level Advanced

Recommended Audience Fellow, Resident, General Neurologist, Specialist Neurologist, Non-neurologist, Advanced Practice Provider, Medical Student

Teaching Styles Case-based, Didactic, Audience Participation

Program Materials Program Evaluations

Event Timeline
07:00 AM - 07:30 AM PDT	Speaker	Overview of Mild Cognitive Impairment Ronald C. Petersen, MD, PhD, FAAN
07:00 AM - 07:00 AM PDT	Speaker	Walk-in Slides Ronald C. Petersen, MD, PhD, FAAN
07:30 AM - 07:50 AM PDT	Speaker	Atypical Forms of MCI Oscar L. Lopez, MD, FAAN
07:50 AM - 08:20 AM PDT	Speaker	Treatments for MCI David J. Gill, MD, FAAN
08:20 AM - 09:00 AM PDT	Discussion	Case Studies of MCI Ronald C. Petersen, MD, PhD, FAAN, Oscar L. Lopez, MD, FAAN, David J. Gill, MD, FAAN

Faculty Disclosures
Ronald C. Petersen, MD, PhD, FAAN	Dr. Petersen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Petersen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Petersen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eli Lilly and Co.. Dr. Petersen has received personal compensation in the range of $0-$499 for serving as a Consultant for Eisai, Inc.. Dr. Petersen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novo Nordisk. Dr. Petersen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Petersen has received publishing royalties from a publication relating to health care. Dr. Petersen has received publishing royalties from a publication relating to health care. Dr. Petersen has received publishing royalties from a publication relating to health care. Dr. Petersen has a non-compensated relationship as a Board of Directors with American Brain Foundation that is relevant to AAN interests or activities.
Oscar L. Lopez, MD, FAAN	Dr. Lopez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Acumen.
David J. Gill, MD, FAAN	Dr. Gill has nothing to disclose.

��ɫ��

��ɫ��